Anifrolumab (Saphnelo) listed in SK

May 1, 2024 – Lupus Canada is pleased to share that Lupus Awareness Month is kicking off with a Saphnelo listing in Saskatchewan effective May 1st, 2024.  With this listing, Saphnelo is now covered by 86% of Canadian public drug reimbursement plans. For more...

Belimumab (Benlysta) listed in AB, NL & NIHB

April 30, 2024 – Lupus Canada is pleased to share updates to the Benlysta listing in the following provinces: NL – Criteria-Apr-2024.pdf (gov.nl.ca) AB – Full April 1, 2024 – Alberta Drug Benefit List (bluecross.ca) NIHB...

Belimumab (Benlysta) listed in ON

April 29, 2024 – Lupus Canada is pleased to share that Benlysta (indication Lupus Nephritis) is listed in Ontario effective April 17, 2024. SUMMARY OF PRODUCT CHANGES We are pleased to provide you with the Summary of Changes – April 2024 to Edition No. 43 of...